Calquence 100 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FYQHF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,594
Award facts
- Contract value 100% obligated
- $5,593.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Calquence 100 mg tablets (60-count) valued at $5,593.77. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by September 30, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that serves as the company's primary vehicle for pharmaceutical supply to federal military and healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial federal contracting portfolio with the Defense Logistics Agency focused on supplying medications and medical commodities to military healthcare programs. The company's federal awards demonstrate capability across diverse pharmaceutical categories including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The DLA Troop Support Medical contract vehicle enables AmerisourceBergen to serve multiple federal customers including the Defense Health Agency and U.S. Coast Guard with global pharmaceutical support capabilities. This delivery order for Calquence—a specialty medication used in hematologic malignancy treatment—exemplifies the company's role in ensuring critical pharmaceutical availability within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FYQHF?
SPE2DB25FYQHF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FYQHF worth?
The government has obligated $5,594 on SPE2DB25FYQHF.
Is contract SPE2DB25FYQHF an order under another contract?
Yes. SPE2DB25FYQHF is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYQHF competed?
The extent of competition for SPE2DB25FYQHF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award